Scientists are making big strides in developing tiny devices that can be injected into the bloodstream to help with brain treatments. Instead of using traditional implants that require surgery, these new tech hybrids hitch a ride on immune cells to reach specific spots in the brain, especially areas affected by diseases or inflammation.

How These Cell-Carried Chips Work

The idea is to create super-small electronic devices that can travel through blood vessels like regular cells. These devices are built using advanced chip technology and are coated with special chemicals. Once injected, they attach to immune cells called monocytes, which naturally move toward inflammation in the body. This way, the devices are carried directly to their target, crossing the brain’s protective barrier without invasive surgery.

Overcoming Major Challenges

Making these tiny devices is no easy feat. Researchers used a process similar to making computer chips, making them just a few hundred nanometers thick and about 10 microns wide—small enough to fit inside a cell. They also needed a way to power these chips remotely. The team used infrared light, which can penetrate tissue, to activate and power the devices once they reached their destination. To attach the electronics to the immune cells, they used a chemical trick called click chemistry, which is like snapping two LEGO pieces together, ensuring a quick and strong connection.

Testing in Mice and Future Possibilities

In experiments with mice, scientists created inflammation in specific brain regions. They then injected the cell-electronic hybrids into the bloodstream. After about three days, most of these hybrids reached the inflamed area, staying attached to the immune cells. When exposed to infrared light, the devices activated nearby neurons just like traditional brain implants, but without surgery.

This approach is especially promising for treating brain diseases like glioblastoma or DIPG, where current surgeries are too risky or impossible. By tailoring these hybrids, scientists hope to target different conditions, including neurodegenerative diseases like Alzheimer’s, or even tumors, using different types of immune or stem cells.

The biggest game-changer is that these devices can be designed to fully degrade after their job is done. This means they could be used for temporary studies or treatments in healthy brains without leaving permanent implants. Sarkar, the lead researcher, sees this as a step toward brain-computer interfaces that are less invasive and more adaptable, possibly even enhancing human capabilities in the future.

While these hybrids are not quite sci-fi nanobots, they represent a major advance in medical technology. They could make brain treatments safer, more precise, and accessible, opening new doors for both research and medicine.

Inspired by

• https://arstechnica.com/science/2025/11/tiny-chips-hitch-a-ride-on-immune-cells-to-sites-of-inflammation/

Sources

• conde.digital
• cnevids.com
• nobelprize.org
• doi.org